Status:
RECRUITING
FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role
Lead Sponsor:
International Extranodal Lymphoma Study Group (IELSG)
Conditions:
Marginal Zone Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
The general aim of the present study is to assess the role of PET for the staging and for the assessment of response and outcome prediction in Marginal Zone Lymphoma (MZL). This study will be conducte...
Detailed Description
A significant proportion of patients considered for this study will be retrieved from previous observational prospective clinical studies. Data on clinical presentation, treatment and follow-up will b...
Eligibility Criteria
Inclusion
- One of the following subtypes of Histology confirmed Indolent non-follicular B-cell lymphoma:
- Splenic MZL (bone marrow histology and/or splenic tissue);
- Extranodal MZL or MALT (tissue biopsy);
- Nodal MZL (lymph node biopsy).
- Age over 18.
- Availability of details on clinical presentation, treatment details and results, and on follow-up.
- Execution of PET at diagnosis or/and at end of treatment or/and at relapse.
- Execution of CT scan with iodine contrast medium at diagnosis and at assessment of response.
- Patients with histologically confirmed marginal zone lymphomas according to the current WHO classification are registered in the study. Diagnosis based on tru-cut core-needle biopsies are permitted in the study.
- Written informed consent.
Exclusion
- Patients with a diagnosis of Non Hodgkin Lymphoma other than MZL.
- Scans images not available for whatever reason.
- Cases diagnosed on fine needle aspiration cytology only.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2025
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04333524
Start Date
December 1 2020
End Date
December 15 2025
Last Update
October 26 2024
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Dijon
Dijon, France, 21000
2
Saint Louis Hospital
Paris, France
3
IUCT Oncopole Toulouse
Toulouse, France, 31100
4
ASO SS. Antonio e Biagio e C. Arrigo
Alessandria, AL, Italy, 15121